File:Degarelix Benefits to Reduce the Risk of Cardiovascular Events in Prostate Cancer Treatment.docx

From OpenWetWare
Jump to: navigation, search
Warning: This file type may contain malicious code. By executing it, your system may be compromised.

Degarelix (INN) or degarelix acetate (USAN) (trade name Firmagon) has an immediate onset of action, binding to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocking their interaction with GnRH. Reference can be found at http://www.creative-peptides.com/product/degarelix-item-10-101-132-37.html.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeDimensionsUserComment
current00:37, 16 June 2016 (13 KB)Chloe Mica (talk | contribs)Degarelix (INN) or degarelix acetate (USAN) (trade name Firmagon) has an immediate onset of action, binding to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocking their interaction with GnRH. Reference can be found at http
  • You cannot overwrite this file.

There are no pages that link to this file.